Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists

Blood

Volumn 87, Issue 12, 1996, Pages 4959-4966

  Estaquier, Jérôme ^a   Tanaka, Masato ^b   Suda, Takashi ^b   Nagata, Shigekazu ^b   Golstein, Pierre ^b   Ameisen, Jean Claude ^a  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CD4 ANTIGEN; CD8 ANTIGEN; CYSTEINE PROTEINASE; CYTOKINE; FAS ANTIGEN; HOE 33342; INTERLEUKIN 1BETA CONVERTING ENZYME; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEINASE INHIBITOR; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 7; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG THERAPY; ETIOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVENTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEINASE INHIBITION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

EID: 0029992895     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.4959.bloodjournal87124959     Document Type: Article

References (41)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995
2. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, HIV-seropositive patients. J Clin Invest 84:1892, 1989
3. Ameisen JC, Capron A: Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol Today 12:102, 1991
4. Ameisen JC, Estaquier J, Idziorek T: From AIDS to parasite infection: Pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol Rev 142:9, 1994
5. Groux H, Torpier G, Monté D, Mouton Y, Capron A, Ameisen JC: Activation-induced death by apoptosis in CD4+ T Cells from HIV-infected asymptomatic individuals. J Exp Med 175:331, 1992
6. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet IPM, Miedema F: Programmed cell death of T cells in HIV-1 infection. Science 257:217, 1992
7. Gougeon M-L, Garcia S, Heeney J, Tschopp R, Lecoeur H, Guétard D, Rame V, Dauguet C, Montagnier L: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 9:553, 1993
8. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Pahwa S: Accelerated apoptosis in PBMCs from HIV-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392, 1993
9. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, Henkart PA: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for HIV pathogenesis. Proc Natl Acad Sci USA 91:11811, 1994
10. Estaquier J, Idziorek T, De Bels F, Barré-Sinoussi F, Hurtrel B, Aubertin AM, Venet A, Mehtali M, Muchmore E, Michel P, Mouton Y, Girard M, Ameisen JC: Programmed cell death and AIDS: the significance of T-cell apoptosis in pathogenic and non pathogenic primate lentiviral infections. Proc Natl Acad Sci USA 91:9431, 1994
11. Lewis DE, Ng Tang DS, Adu-Oppong A, Schober W, Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 153:412, 1994
12. Sarin A, Clerici M, Blatt SP, Hendrix CW, Shearer GM, Henkart PA: Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J Immunol 153:862, 1994
13. Muro-Cacho CA, Pantaleo G, Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with the stage of disease or viral burden. J Immunol 154:5555, 1995
14. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupper A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1:129, 1995
15. Del Liano AM, Amieiro-Puig JP, Kraiselburd EN, Kessler MJ, Malaga CA, Lavergne JA: The combined assessment of cellular apoptosis, mitochondrial function and proliferative response to pokeweed mitogen has prognostic value in SIV infection. J Med Primatol 22:194, 1993
16. Schuitemaker H, Meyaard L, Koostra N, Otto S, Dubbes R, Tersmette M, Heeney J, Miedema F: Lack of T-cell dysfunction and programmed cell death correlates with inability of HIV-1 to infect chimpanzee monocytes. J Infect Dis 168:1140, 1993
17. Banda NK, Bernier J, Kurahara DK, Kurde R, Haigwood N, Sekaly RP, Finkel TH: Crosslinking CD4 by HIV gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099, 1992
18. Laurent-Crawford AG, Krust B, Rivière Y, Desgranges C, Muller S, Kieny MP, Dauguet C, Hovanessian AG: Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses 9:761, 1993
19. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429, 1995
20. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497, 1995
21. Katsikis PD, Wunderlich ES, Smith CA, Hertzenberg LA, Hertzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in HIV-infected individuals. J Exp Med 181:2029, 1995
22. Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM, Ameisen JC: Th1/Th2 cytokines and T-cell death: Preventive effect of IL-12 on activation-induced and CD95 (Fas/Apo-1)-mediated apoptosis of CD4+ T cells from HIV-infected persons. J Exp Med 182:1759, 1995
23. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, Ishii A: Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 6:1849, 1994
24. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129, 1995
25. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
26. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol 6:1567, 1994
27. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
28. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K: Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature 375:81, 1995
29. Darmon AJ, Nicholson DW, Bleakley RC: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446, 1995
30. Martin S, Green D: Protase activation during apoptosis: Death by a thousand cuts? Cell 82:349, 1995
31. Milligan C, Prevette D, Yaginuma H, Homma S, Cardwell C, Fritz LC, Tomaselli KJ, Oppenheim RW, Schwartz LM: Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15:385, 1995
32. Tornberry N, Bull H, Calaycay J, Chapman K, Howard A, Kostura M, Miller D, Molineaux S, Weidner J, Aunins J, Elliston K, Ayala J, Casano F, Chin J, Ding G, Egger L, Gaffney E, Limjuco G, Palyha O, Raju S, Rolando A, Salley P, Yamin T, Lee T, Shively J, MacCross M, Mumford R, Schmidt J, Tocci M: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768, 1992
33. Nicholson D, Ali A, Thornberry N, Vaillancourt J, Ding C, Gallant M, Gareau Y, Griffin P, Labelle M, Lazebnik Y, Munday N, Raju S, Smulson M, Yamin T, Yu V, Miller D: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
34. Idziorek T, Estaquier J, De Bels F, Ameisen JC: YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods 185:249, 1995
35. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
36. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
37. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625, 1993
38. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251, 1995
39. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by TNF. Nature 377:348, 1995
40. Arase H, Arase N, Saito T: Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235, 1995
41. + T lymphocytes with intermittent courses of IL-2 in patients with HIV infection. N Engl J Med 332:567, 1995